A neuropharmacological study of the periventricular neural substrate involved in flight

doi:10.1016/0166-4328(86)90039-2

Behavioural Brain Research

Volume 22, Issue 2, November 1986, Pages 181-190

https://doi.org/10.1016/0166-4328(86)90039-2 Get rights and content

Abstract

This paper reviews results obtained in experiments concerning the neurochemical characteristics of the substrate involved in the control of flight reactions and the induction of aversive effects in the rat. These experiments investigated the behavioural effects produced by microinjecting into the periaqueductal grey matter (PAG) or the medial hypothalamus (MH) compounds known to interfere with the functioning of some neurotransmitter systems known to exist in these structures. The data obtained show that: (1) the activity of the substrate involved in the production of flight reactions is tonically inhibited by the release of GABA (γ-aminobutyric acid); (2) the behavioural reactions produced by microinjecting GABA antagonists can be clearly distinguished, depending on whether such drugs were injected into the PAG or the MH, despite the fact that jumps were produced from either level; (3) behavioural effects, comparable to some extent to those produced by microinjections of GABA antagonists, can be obtained by injecting drugs which act on non-GABAergic neurochemical substrates, namely opioidergic or cholinergic systems; and (4) behavioural effects, comparable to those produced by injecting GABA antagonists into the PAG, can be obtained by injecting such drugs into various sites located in other parts of the tectum such as the inferior colliculus or adjacent structures.

References (68)

R. Bandler
Induction of ‘rage’ following microinjection of glutamate into midbrain but not hypothalamus of cats
Neurosci. Lett.
(1982)
R.J. Bandler et al.
Identification of midbrain neurones mediating defensive behaviour in the rat by microinjections of excitatory amino acids
Behav. Brain Res.
(1985)
A.J. Beitz
The organization of afferent projections to the mid brain periaqueductal gray of the rat
Neuroscience
(1982)
M.L. Brandao et al.
Gaba mediation of the anti-aversive action of minor tranquilizers
Pharmacol. Biochem. Behav.
(1982)
M.L. Brandao et al.
Chlordiazepoxide and morphine reduce pressor response to brain stimulation in awake rats
Pharmacol. Biochem. Behav.
(1985)
M.L. Brandao et al.
Escape behaviour produced by blockade of glutamic acid decarboxylase (GAD) in mesencephalic central gray or medial hypothalamus
Pharmacol. Biochem. Behav.
(1986)
A. Carobrez et al.
Neuroeffector mechanisms of the defence reaction in the rat
Physiol. Behav.
(1983)
G. Chevalier et al.
Evidence for a GABAergic inhibitory nigrotectal pathway in the rat
Neurosci. Lett.
(1981)
A.R. Cools et al.
Picrotoxin microinjections into the brain: a model of abrupt withdrawal ‘jumping’ behaviour in rats not exposed to any opiate?
Eur. J. Pharmacol.
(1983)
A.R. Cools et al.
The striato-nigro-collicular pathway and explosive running behaviour: functional interaction between neostriatal dopamine and collicular GABA
Eur. J. Pharmacol.
(1984)

A. Depaulis et al.

Elicitation of intraspecific defensive behavior in the rat by microinjections of picrotoxin, a γ-aminobutyric antagonist, into the midbrain periaqueductal gray matter

Brain Res.

(1986)

G. Di Scala et al.

Unilateral injection of GABA agonists in the superior colliculus: asymmetry to tactile stimulation

Pharmacol. Biochem. Behav.

(1983)

E. Garcia-Rill et al.

Chemical activation of the mesencephalic locomotor region

Brain Res.

(1985)

A. Imperato et al.

Behavioural effects of GABA agonists and antagonists infused in the mesencephalic reticular formation-deep layers of superior colliculus

Brain Res.

(1981)

Y.F. Jacquet et al.

Morphine and ACTH_1–24: correlative behavioral excitations following micro-injections in the rat periaqueductal gray

Brain Res.

(1981)

F. Jenck et al.

Morphine applied to the mesencephalic central gray suppresses brain stimulation induced escape

Pharmacol. Biochem. Behav.

(1983)

F. Jenck et al.

Role of opiates and benzodiazepines in the control of centrally induced aversive effects

Behav. Brain Res.

(1984)

F. Jenck et al.

Morphine injected into the periaqueductal gray attenuates brain-stimulation-induced aversive effects: an intensity discrimination study

Brain Res.

(1986)

R. Lappuke et al.

Discrimination between aversive brain stimulations: effect of stimulation parameter

Behav. Neural. Biol.

(1984)

J.E. Marchand et al.

Afferents to the periaqueductal gray in the rat

A Horseradish peroxidase study

Neuroscience

(1983)

B.J. Morley et al.

Escape from stimulation of the trapezoid body in rats bred for escape from noise

Physiol. Behav.

(1977)

Q.J. Pittman et al.

Influence of midbrain stimulation on the excitability of neurons in the medial hypothalamus of the rat

Brain Res.

(1979)

G.S. Ross et al.

Forelimb and hindlimb stepping by the anesthetized rat elicited by electrical stimulation of the pons and medulla

Physiol. Behav.

(1984)

G. Sandner et al.

Central gray and medial hypothalamic stimulation: correlation between escape behavior and unit activity

Brain Res.

(1979)

G. Sandner et al.

Effects of hypothalamic lesions on central gray stimulation induced escape behavior and on withdrawal reactions in the rat

Physiol. Behav.

(1985)

P. Schmitt et al.

Etude des systèmes de renforcement négatif et de renforcement positif au niveau de la substance grise centrale chez le rat

Physiol. Behav.

(1974)

P. Schmitt et al.

Effets aversifs et appétitifs induits par stimulation mésencéphalique et hypothalamique

Brain Res.

(1977)

P. Schmitt et al.

Effects of central gray and raphe nuclei lesions on hypothalamically induced escape

Physiol. Behav.

(1979)

P. Schmitt et al.

Escape induced by combined stimulation in medial hypothalamus and central gray

Physiol. Behav.

(1980)

P. Schmitt et al.

Escape and approach induced by brain stimulation: a parametric analysis

Behav. Brain Res.

(1981)

P. Schmitt et al.

Behavioral effects of microinjections of SR 95103, a new GABA_A antagonist, into the medial hypothalamus or the mesencephalic central gray

Eur. J. Pharmacol.

(1985)

L.G. Sharpe et al.

Analgesia and hyperreactivity produced by intracranial micro-injections into the PAG of the rat

Behav. Biol.

(1974)

M.S. Starr et al.

Role of the ventromedial nucleus of the thalamus in motor behavior. I. Effects of focal injections of drugs

Neuroscience

(1983)

G. Tredici et al.

Short intrinsic circuit in the periaqueductal gray matter of the cat

Neurosci. Lett.

(1983)

Cited by (63)

Dual role of dopamine D<inf>2</inf>-like receptors in the mediation of conditioned and unconditioned fear
2015, FEBS Letters
A reduction of dopamine release or D₂ receptor blockade in the terminal fields of the mesolimbic system, particularly the amygdala, clearly reduces conditioned fear. Similar D₂ receptor antagonism in the neural substrates of fear in the midbrain tectum attenuates the processing of unconditioned aversive information. However, the implications of the interplay between opposing actions of dopamine in the rostral and caudal segments of the dopaminergic system are still unclear. Previous studies from this laboratory have reported the effects of dopaminergic drugs on behavior in rats in the elevated plus maze, auditory-evoked potentials (AEPs) recorded from the midbrain tectum, fear-potentiated startle, and conditioned freezing. These findings led to an interesting framework on the functional roles of dopamine in both anxiety and fear states. Dopamine D₂ receptor inhibition in the terminal fields of the mesolimbic dopamine system generally causes anxiolytic-like effects, whereas the activity of midbrain substrates of unconditioned fear are enhanced by D₂ receptor antagonists, suggesting that D₂ receptor-mediated mechanisms play opposing roles in fear/anxiety processes, depending on the brain region under study. Dopamine appears to mediate conditioned fear by acting at rostral levels of the brain and regulate unconditioned fear at the midbrain level, likely by reducing the sensorimotor gating of aversive events.
Dorsomedial hypothalamus CRF type 1 receptors selectively modulate inhibitory avoidance responses in the elevated T-maze
2014, Behavioural Brain Research
Citation Excerpt :
In fact, the electrical stimulation of the DMH induces escape behavior and autonomic arousal that resemble the ones presented by animals when facing natural threats [18–20]. Administration of glutamate agonists [13,21] and of GABA antagonists into the structure [22,23] also evokes a similar defense pattern. CRF positive neurons have been shown to be present in large numbers in the DMH [24].
Corticotropin-releasing factor (CRF) plays a critical role in the mediation of physiological and behavioral responses to stressors. In the present study, we investigated the role played by the CRF system within the dorsomedial hypothalamus (DMH) in the modulation of anxiety- and panic-related responses. Male Wistar rats were administered into the DMH with CRF (125 and 250 ng/0.2 μl, experiment 1) or with the CRFR1 antagonist antalarmin (25 ng/0.2 μl, experiment 2) and 10 min later tested in the elevated T-maze (ETM) for inhibitory avoidance and escape measurements. In clinical terms, these responses have been respectively related to generalized anxiety and panic disorder. To further verify if the anxiogenic effects of CRF were mediated by CRFR1 activation, we also investigated the effects of the combined treatment with CRF (250 ng/0.2 μl) and antalarmin (25 ng/0.2 μl) (experiment 3). All animals were tested in an open field, immediately after the ETM, for locomotor activity assessment. Results showed that 250 ng/0.2 μl of CRF facilitated ETM avoidance, an anxiogenic response. Antalarmin significantly decreased avoidance latencies, an anxiolytic effect, and was able to counteract the anxiogenic effects of CRF. None of the compounds administered altered escape responses or locomotor activity measurements. These results suggest that CRF in the DMH exerts anxiogenic effects by activating type 1 receptors, which might be of relevance to the physiopathology of generalized anxiety disorder.
Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus
2014, Neuroscience
Chemical and electrical stimulation of the inferior colliculus (IC) causes defensive behavior. Electrical stimulation of the IC at the escape threshold enhances dopamine (DA) release in the prefrontal cortex. Intra-ventral tegmental area injections of quinpirole at doses that act presynaptically reduce the release of DA in the terminal fields of the mesolimbic system and clearly reduce conditioned fear in several animal models of anxiety. However, little is known about the involvement of DA in the mediation of unconditioned fear, such as the reactivity to acute stressors. The present study investigated the neural substrates mediated by DA transmission associated with emotional changes triggered by the activation or inhibition of D₂ receptors during conditioned and unconditioned fear. We examined the effects of systemic or local injections of the DA-receptor antagonist and agonist haloperidol and quinpirole, respectively, into the IC in rats subjected to fear-potentiated startle, a Pavlovian paradigm that uses loud sounds as the unconditioned stimulus and light previously paired with footshock as the conditioned stimulus. We also assessed auditory-evoked potentials (AEPs) recorded from electrodes implanted in the IC. Intraperitoneal haloperidol administration dose-dependently enhanced AEPs induced by loud tones and inhibited fear-potentiated startle. Intra-IC injections of quinpirole left AEPs unchanged, suggesting that an optimal level of postsynaptic D₂ receptors in the IC may regulate the transmission of aversive information through the midbrain tectum. These findings provide evidence of opposing DA-mediated mechanisms in fear/anxiety processes that depend on the area under study. The activity of the neural substrates of conditioned fear was attenuated by haloperidol, whereas midbrain neural substrates of unconditioned fear were enhanced. Thus, DA appears to regulate unconditioned fear at the midbrain level, likely by reducing the sensory gating of aversive events and reducing conditioned fear by acting at more rostral levels of the brain.
Dorsomedial hypothalamus serotonin 1A receptors mediate a panic-related response in the elevated T-maze
2014, Brain Research Bulletin
The dorsomedial hypothalamus (DMH) has long been associated with the regulation of escape, a panic-related defensive response. Previous evidence has shown that the activation of serotonin (5-HT) 1A and 2A receptors impairs escape behavior induced by the electrical stimulation of the same region. In this study we further explore the relationship of the DMH with defense by investigating the effects of 5-HT1A activation on escape behavior generated in male Wistar rats by an ethologically based aversive stimuli, exposure to one of the open arms of the elevated T-maze (ETM). Aside from escape, the ETM also allows the measurement of inhibitory avoidance, a defensive response associated with generalized anxiety disorder. To evaluate locomotor activity, after ETM measurements animals were submitted to an open field. Results showed that intra-DMH administration of the 5-HT1A receptor agonist 8-OH-DPAT inhibited escape expression. Local administration of the 5-HT1A antagonist WAY-100635 by its own was ineffective, but blocked the panicolytic-like effect of 8-OH-DPAT. Chronic (21 days) systemic treatment with imipramine potentiated the anti-escape effect of 8-OH-DPAT. No significant effects of treatment with 8-OH-DPAT or imipramine on avoidance latencies or the number of lines crossed in the open field were found. These results indicate that 5-HT1A receptors within the DMH may play a phasic inhibitory role on ETM escape expression. As previously proposed, facilitation of 5-HT1A-mediated neurotransmission in the DMH may be involved in the mechanism of action of anti-panic compounds.
Chemical neuroanatomical and psychopharmacological evidence that κ receptor-mediated endogenous opioid peptide neurotransmission in the dorsal and ventral mesencephalon modulates panic-like behaviour
2013, European Journal of Pharmacology
Citation Excerpt :
Through the study of encephalic areas and connections involved in the neural basis of innate fear-induced behaviours, several pathways between encephalic aversion system (Graeff, 1990) structures have been found, such the neuroanatomical links between the dorsal columns of the periaqueductal grey matter (dPAG), the medial hypothalamus, the amygdaloid complex, the septal area (Siegel and Pott, 1988), and the reticular formation of the deep mesencephalon, pons and medulla oblonga (Coimbra et al., 2006). These neural substrates have been demonstrated to be physiologically relevant for the elaboration of unconditioned and conditioned fear-induced behaviours and pain modulation in both laboratory animals (Fernandez de Molina and Hunsperger, 1959; Lyon, 1964; Pellegrino, 1968; Halpern, 1968; Fuchs and Siegel, 1984; Fuchs et al., 1985; Schmitt et al., 1986; Coimbra et al., 2006) and humans (Tracey et al., 2002; Mobbs et al., 2007; Wilent et al., 2010). Thus, in addition to other structures such as the deep layers of the superior colliculus (Leão Borges et al., 1988; Coimbra and Brandão, 1993; Coimbra et al., 1996, 2006) and the central nucleus of the inferior colliculus (Brandão et al., 1988, 1993, 2001; Cardoso et al., 1994; Coimbra et al., 2000), the dPAG can be considered an important structure of the encephalic aversion system that is involved in the coordination and generation of instinctive fear-induced behaviour (Graeff, 1981; Fanselow, 1991; Carrive, 1993).
The chemical neuroanatomy and the effects of central administration of opioid antagonists on the innate fear-induced responses elicited by electrical (at escape behaviour threshold) stimulation of the midbrain tectum were determined. The aim of the present work was to investigate the interaction between the tecto-nigral endogenous opioid peptide-mediated disinhibitory pathways and nigro-tectal inhibitory links in the control of panic-like behaviour and their organisation in the continuum comprised by the deep layers of the superior colliculus (dlSC) and the dorsolateral columns of the periaqueductal grey matter (dlPAG). Beta-endorphin-labelled neurons and fibres were found in the dorsal midbrain and also in the substantia nigra. Opioid varicose fibres and terminal buttons were widely distributed in PAG columns and in all substantia nigra subdivisions. Microinjections of naltrexone (a non-selective opioid receptor antagonist; 5.0 μg/0.2 μl) or nor-binaltorphimine (a selective κ-opioid receptor antagonist; 5.0 μg/0.2 μl) in the dlSC/dlPAG continuum, in independent groups of animals, induced significant increases in the escape thresholds for midbrain tectum electrical stimulation. The microinjection of naltrexone or nor-binaltorphimine into the SNpr also increased the escape behaviour threshold for electrical stimulation of dlSC/dlPAG. These morphological and neuropharmacological findings support previous evidence from our team for the role played by the interaction between opioidergic and GABAergic mechanisms in the modulation of innate fear-induced responses. The present data offer a neuroanatomical basis for both intratectal axo-axonic/pre-synaptic and tecto-nigral axo-somatic opioid inhibition of GABAergic nigro-tectal neurons that modulate the dorsal midbrain neurons related to the organisation of fear-related emotional responses.
Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response
2009, Experimental Neurology
Electrical or chemical stimulation of the inferior colliculus (IC) induces fear-like behaviors. More recently, consistent evidence has shown that electrical stimulation of the central nucleus of the IC supports Pavlovian conditioning and latent inhibition (LI). LI is characterized by retardation in conditioning and also by an impaired ability to ignore irrelevant stimuli, after a non-reinforced pre-exposure to the conditioned stimulus. LI has been proposed as a behavioral model of cognitive abnormalities seen in schizophrenia. The aim of the present study was to determine whether dopaminergic mechanisms in the IC are involved in LI of the conditioned emotional response (CER). To induce LI, a group of rats was pre-exposed (PE) to six tones in two sessions, while rats that were not pre-exposed (NPE) had two sessions without tone presentations. The conditioning consisted of two tone presentations to the animal, followed immediately by a foot shock. PE and NPE rats received IC microinjections of physiological saline, the dopaminergic agonist apomorphine (9.0 μg/0.5 μL/side), or the dopaminergic antagonist haloperidol (0.5 μg/0.5 μL/side) before both pre-exposure and conditioning. During the test, the PE rats that received saline or haloperidol had a lower suppression of the licking response compared to NPE rats that received vehicle or haloperidol, indicating that latent inhibition was induced. There was no significant difference in the suppression ratio in rats that received apomorphine injections into the IC, indicating reduced latent inhibition. These results suggest that dopamine-mediated mechanisms of the IC are involved in the development of LI.

View all citing articles on Scopus

View full text